These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12408339)
1. Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Soper R; Himmelreich U; Painter D; Somorjai RL; Lean CL; Dolenko B; Mountford CE; Russell P Pathology; 2002 Oct; 34(5):417-22. PubMed ID: 12408339 [TBL] [Abstract][Full Text] [Related]
3. New OPTN/UNOS classification system for nodules in cirrhotic livers detected with MR imaging: effect on hepatocellular carcinoma detection and transplantation allocation. Rosenkrantz AB; Campbell N; Wehrli N; Triolo MJ; Kim S Radiology; 2015 Feb; 274(2):426-33. PubMed ID: 25299785 [TBL] [Abstract][Full Text] [Related]
4. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216 [TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453 [TBL] [Abstract][Full Text] [Related]
6. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines. Golfieri R; Garzillo G; Ascanio S; Renzulli M Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286 [TBL] [Abstract][Full Text] [Related]
7. Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. Doran ST; Falk GL; Somorjai RL; Lean CL; Himmelreich U; Philips J; Russell P; Dolenko B; Nikulin AE; Mountford CE Am J Surg; 2003 Mar; 185(3):232-8. PubMed ID: 12620562 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in cirrhosis: what's new? Barr DC; Hussain HK Top Magn Reson Imaging; 2014 Apr; 23(2):129-49. PubMed ID: 24690617 [TBL] [Abstract][Full Text] [Related]
10. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI. Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290 [TBL] [Abstract][Full Text] [Related]
11. Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI. Chou CT; Chen RC; Chen WT; Lii JM J Chin Med Assoc; 2011 Feb; 74(2):62-8. PubMed ID: 21354082 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation. Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic imaging of hepatocellular carcinoma in patients with cirrhosis before liver transplantation. Taouli B; Krinsky GA Liver Transpl; 2006 Nov; 12(11 Suppl 2):S1-7. PubMed ID: 17051556 [TBL] [Abstract][Full Text] [Related]
14. Retrospective audit to determine the diagnostic accuracy of Primovist-enhanced MRI in the detection of hepatocellular carcinoma in cirrhosis with explant histopathology correlation. Baird AJ; Amos GJ; Saad NF; Benson MD J Med Imaging Radiat Oncol; 2013 Jun; 57(3):314-20. PubMed ID: 23721140 [TBL] [Abstract][Full Text] [Related]
15. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases. Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. Jeong YY; Yim NY; Kang HK AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427 [TBL] [Abstract][Full Text] [Related]
17. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263 [TBL] [Abstract][Full Text] [Related]
18. Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver. Quaglia A; Jutand MA; Dhillon A; Godfrey A; Togni R; Bioulac-Sage P; Balabaud C; Winnock M; Dhillon AP World J Gastroenterol; 2005 Oct; 11(40):6262-8. PubMed ID: 16419153 [TBL] [Abstract][Full Text] [Related]
19. [An operated case of multiple well-differentiated hepatocellular carcinomas and adenomatous hyperplasia]. Motoo Y; Makuuchi M; Takayama T; Sakamoto M; Hirohashi S; Matsui O; Nakanuma Y; Okai T; Sawabu N Gan No Rinsho; 1990 Apr; 36(5):637-44. PubMed ID: 2157907 [TBL] [Abstract][Full Text] [Related]
20. Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathologic correlation. Krinsky GA; Lee VS; Theise ND J Comput Assist Tomogr; 2000; 24(2):189-96. PubMed ID: 10752877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]